BACK
GLOBAL EXECUTIVE MOVES

May 2021
Zylö Therapeutics Names Charles E. Hinkle as Chief Financial Officer
Zylö Therapeutics announced that Charles E. Hinkle joined its Executive Team as Chief Financial Officer.
Zylö Therapeutics is a company based in South Carolina that has an innovative sustained-release topical delivery system that uses patented xerogel-derived silica particles, called Z-pods™, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration.